跳至主要内容
临床试验/NCT03262155
NCT03262155已完成不适用

Study of Immunity Dysfunction Induced by Extracorporeal Assistance (ECMO / ECLS)

Rennes University Hospital1 个研究点 分布在 1 个国家目标入组 18 人开始时间: 2017年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
18
试验地点
1
主要终点
Prevalence of immunosuppression in patients with ARDS or cardiogenic shock under ECMO / ECLS hospitalized in intensive care unit

研究概览

简要总结

Study of immunosuppression biomarkers in patients with ARDS or cardiogenic shock with ECMO / ECLS, compared to patients with ARDS or cardiogenic shock without ECMO / ECLS

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient older than 18 years old
  • Patient hospitalized in an intensive care unit
  • Patient whose initial ARDS or Cardiogenic shock began less than 5 days before admission
  • Patients hospitalized for ARDS or Cardiogenic shock with ECMO / ECLS or - Patients hospitalized for ARDS or Cardiogenic shock without ECMO / ECLS

排除标准

  • Opposition of patient, relative or legal representative for participation in the study
  • Pregnant woman
  • Pre-immunodepression
  • Implementation of immunosuppressive therapy such as chemotherapy, cyclophosphamide, high-dose corticosteroids (> 0.5mg / kg / day).

结局指标

主要结局

Prevalence of immunosuppression in patients with ARDS or cardiogenic shock under ECMO / ECLS hospitalized in intensive care unit

时间窗: Hour 24

次要结局

未报告次要终点

研究者

发起方
Rennes University Hospital
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验